James Komorowski, MS, CNS, vice president of scientific and regulatory affairs at Nutrition 21, presented the results of three preclinical studies on Nutrition 21’s patented amylopectin and chromium combination ingredient, Velositol, at the ISSN (International Society of Sports Nutrition) conference on June 24th in Phoenix.
Bionano Genomics and Genoptix today announced an exclusive agreement to codevelop diagnostic assays for selected hematologic oncology indications. Bionano will contribute its knowledge of genome structure analysis and its Saphyr system, which is designed to accurately visualize the structure of a genome with a simple DNA sample, isolated directly from cancer cells. The platform can …
Another noteworthy feature of emerging managers is that many of them have created new or different models for their firms and for making VC investments. “We leverage a unique, team-based operating partner model of CEO and longtime executive partners who collaborate with us,” said Adele Oliva, Founding Partner of Philadelphia-based healthcare expansion and growth equity …
1315 Capital, LLC, an expansion and growth equity firm that invests in commercial-stage specialty pharmaceutical, medical technology, and healthcare services companies, announced today the continued expansion of its senior investment team with the addition of Matthew Q. Reber as a Partner. Mr. Reber joins Founding Partners, Adele C. Oliva and Michael Koby, and brings deep …
Chromium picolinate has long been known for its positive effects on glucose metabolism when it comes to weight management. However, more than 35 clinical studies on humans have been completed on a brand of chromium picolinate called Chromax, a dietary supplement ingredient developed by Nutrition 21.
Onkos Surgical announced the completion of the company’s first ELEOS Limb Salvage System procedure using uDesign Patient Solutions. uDesign delivers an interactive experience, enabling a personalized planning approach for each patient. The first surgery was conducted by Steven Gitelis, M.D., of Rush University Medical Center in Chicago.
Onkos Surgical, Inc., a specialty medtech company focused on surgical oncology, today announced that it closed a $17.6 million round in Series B funding. Canaan Partners led the funding round and existing investors 1315 Capital and 3D Systems also participated. Onkos will use the new funding to expand its sales, marketing, and R&D platforms to …
Onkos Surgical, an innovative surgical oncology company, has announced today it has partnered with PatientIQ, a healthcare data, research and analytics technology company, to launch a platform for the collection of clinical data for surgical oncology patients.
An experienced management team, led by Joseph M. Limber, in partnership with Ampersand Capital Partners and 1315 Capital, has completed the acquisition of Genoptix, Inc. from Novartis. The financial terms of the transaction are not being disclosed. Headquartered in Carlsbad, California, Genoptix is a recognized leader in its field, and is one of the largest …
A new study published in Journal of the International Society of Sports Nutrition shows the combination of amylopectin and chromium in Nutrition 21’s patented ingredient Velositol doubles the muscle protein synthesis rate compared to what was seen when using whey protein alone.